The Europe market for the orthobiologics is anticipated to grow at CAGR of 5.04%. The forecast period of the orthobiologics market in the Europe region is from 2019 to 2027. The European market is termed to be the second largest market for orthobiologics market owing to the rising cases in osteoarthritis and osteoporosis.
EUROPE ORTHOBIOLOGICS MARKET FORECAST 2019-2027
Europe Orthobiologics Market by End-user (Hospitals, Orthopedic Clinics) by Products (Demineralized Bone Matrix (Dbm), Allograft, Bone Morphogenetic Protein (Bmp), Viscosupplementation, Synthetic Bone Substitutes, Stem Cell Therapy, Other Products) by Application (Spinal Fusion, Trauma Repair, Reconstructive Surgery, Tendon and Ligament, Other Applications) by Geography.
The Europe market for the orthobiologics is anticipated to grow at CAGR of 5.04%. The forecast period of the orthobiologics market in the Europe region is from 2019 to 2027. The European market is termed to be the second largest market for orthobiologics market owing to the rising cases in osteoarthritis and osteoporosis.
Also, the technological expansions in the European countries are driving the market to grow at a quicker pace, and there is a booming demand for bone graft substitutes and other biologics making a positive impact. The countries analyzed in the Europe region of the orthobiologics market are United Kingdom, France, Germany, Spain, Italy and the Rest of Europe.
According to national health services of UK, people aging 65 years and above are at a higher risk of orthopedic disorders which is one of the fundamental driving forces of the UK Market further contributing to the market at a global scale.
However, high costs incurred coupled with poor transplant techniques is hampering the growth of the European market in the forecasting period of 2019-2027.
AAP Implantate AG, Allosource, Amedica Corporation, Baxter International Inc., Conmed Corporation, Depuy Inc. (acquired by Johnson and Johnson), Exactech Inc., Integra Lifesciences Holding Corporation, Medtronic Inc., Nuvasive Inc., RTI Surgical, Sanofi, Smith & Nephew PLC, Stryker Corporation and Zimmer Biomet Inc. are the companies mentioned in the report.
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE
- STUDY GOALS
- SCOPE OF THE MARKET STUDY
- WHO WILL FIND THIS REPORT USEFUL?
- STUDY AND FORECASTING YEARS
- RESEARCH METHODOLOGY
- SOURCES OF DATA
- SECONDARY DATA
- PRIMARY DATA
- TOP DOWN APPROACH
- BOTTOM-UP APPROACH
- DATA TRIANGULATION
- SOURCES OF DATA
- EXECUTIVE SUMMARY
- MARKET SUMMARY
- KEY FINDINGS
- HOSPITALS ARE THE LARGEST REVENUE GENERATING END-USER
- SPINAL FUSION IS THE FASTEST GROWING APPLICATION
- VISCOSUPPLEMENTATION HOLDS THE LARGEST MARKET SHARE IN TERMS OF PRODUCTS
- MARKET DYNAMICS
- MARKET SCOPE & DEFINITION
- MARKET DRIVERS
- INCREASING GERIATRIC POPULATION
- INCREASE ORTHOPAEDIC RELATED DISEASES DUE TO LIFESTYLE CHOICES
- TECHNOLOGICAL ADVANCEMENT
- MARKET RESTRAINTS
- STRINGENT GOVERNMENT POLICIES
- POST-SURGERY COMPLICATIONS
- HIGH COST OF ORTHOPEDICS IMPLANTS
- MARKET OPPORTUNITIES
- INCREASED UTILIZATION OF BONE REGENERATION TECHNOLOGY
- GROWING DISPOSABLE INCOME
- EXPANSION OF COST EFFECTIVE MEDICAL PRODUCTS
- HUGE MARKET OPPORTUNITIES IN DEVELOPING COUNTRIES
- MARKET CHALLENGES
- HIGH COST OF SPINAL FUSION SURGERY
- POOR PERFORMANCE OF BONE GRAFT SUBSTITUTE
- MARKET BY END-USER
- HOSPITALS
- ORTHOPEDIC CLINICS
- MARKET BY PRODUCTS
- DEMINERALIZED BONE MATRIX (DBM)
- ALLOGRAFT
- BONE MORPHOGENETIC PROTEIN (BMP)
- VISCOSUPPLEMENTATION
- SYNTHETIC BONE SUBSTITUTES
- STEM CELL THERAPY
- OTHER PRODUCTS
- MARKET BY APPLICATION
- SPINAL FUSION
- TRAUMA REPAIR
- RECONSTRUCTIVE SURGERY
- TENDON AND LIGAMENT
- OTHER APPLICATIONS
- KEY ANALYTICS
- PORTER’S FIVE FORCE MODEL
- THREAT OF NEW ENTRANTS
- THREAT OF SUBSTITUTE
- BARGAINING POWER OF BUYER
- BARGAINING POWER OF SUPPLIER
- INTENSITY OF COMPETITIVE RIVALRY
- PESTEL ANALYSIS
- PATENT ANALYSIS
- KEY BUYING CRITERIA
- VALUE CHAIN ANALYSIS
- OPPORTUNITY MATRIX
- PORTER’S FIVE FORCE MODEL
- GEOGRAPHICAL ANALYSIS
- EUROPE
- THE UNITED KINGDOM
- FRANCE
- GERMANY
- SPAIN
- ITALY
- REST OF EUROPE
- EUROPE
- COMPETITIVE LANDSCAPE
- MARKET SHARE ANALYSIS
- COMPANY PROFILES
- AAP IMPLANTATE AG
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- ALLOSOURCE
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVE
- AMEDICA CORPORATION
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- BAXTER INTERNATIONAL INC.
- MARKET OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- CONMED CORPORATION
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- DEPUY INC. (ACQUIRED BY JOHNSON AND JOHNSON)
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- EXACTECH INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVES
- INTEGRA LIFESCIENCES HOLDING CORPORATION
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- MEDTRONIC INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVES
- NUVASIVE INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- RTI SURGICAL
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- SANOFI
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- SMITH & NEPHEW PLC
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVES
- STRYKER CORPORATION
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVES
- ZIMMER BIOMET INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- AAP IMPLANTATE AG
TABLE LIST
TABLE 1 EUROPE ORTHOBIOLOGICS MARKET 2019-2027 ($ MILLION)
TABLE 2 POST-SURGERY COMPLICATION
TABLE 3 EUROPE ORTHOBIOLOGICS MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 4 EUROPE HOSPITALS MARKET 2019-2027 ($ MILLION)
TABLE 5 EUROPE ORTHOPEDIC CLINICS MARKET 2019-2027 ($ MILLION)
TABLE 6 EUROPE ORTHOBIOLOGICS MARKET BY PRODUCTS 2019-2027 ($ MILLION)
TABLE 7 EUROPE DEMINERALIZED BONE MATRIX (DBM) MARKET 2019-2027 ($ MILLION)
TABLE 8 EUROPE ALLOGRAFT MARKET 2019-2027 ($ MILLION)
TABLE 9 EUROPE BONE MORPHOGENETIC PROTEIN (BMP) MARKET 2019-2027 ($ MILLION)
TABLE 10 EUROPE VISCOSUPPLEMENTATION MARKET 2019-2027 ($ MILLION)
TABLE 11 EUROPE SYNTHETIC BONE SUBSTITUTES MARKET 2019-2027 ($ MILLION)
TABLE 12 EUROPE STEM CELL THERAPY MARKET 2019-2027 ($ MILLION)
TABLE 13 EUROPE OTHER PRODUCTS MARKET 2019-2027 ($ MILLION)
TABLE 14 EUROPE ORTHOBIOLOGICS MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 15 EUROPE SPINAL FUSION MARKET 2019-2027 ($ MILLION)
TABLE 16 EUROPE TRAUMA REPAIR MARKET 2019-2027 ($ MILLION)
TABLE 17 EUROPE RECONSTRUCTIVE SURGERY MARKET 2019-2027 ($ MILLION)
TABLE 18 EUROPE TENDON AND LIGAMENT MARKET 2019-2027 ($ MILLION)
TABLE 19 EUROPE OTHER APPLICATIONS MARKET 2019-2027 ($ MILLION)
TABLE 20 EUROPE ORTHOBIOLOGICS MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 21 AGE STRUCTURE OF GERMANY 2017
FIGURES LIST
FIGURE 1 EUROPE ORTHOBIOLOGICS MARKET 2019-2027 ($ MILLION)
FIGURE 2 INCREASING DEMAND OF MINIMAL INVASIVE TECHNOLOGIES 2010-2025 ($ MILLION)
FIGURE 3 EUROPE ORTHOBIOLOGICS MARKET SHARE BY END USER 2018 & 2027 (%)
FIGURE 4 EUROPE ORTHOBIOLOGICS MARKET BY HOSPITALS 2019-2027 ($ MILLION)
FIGURE 5 EUROPE ORTHOBIOLOGICS MARKET BY ORTHOPEDIC CLINICS 2019-2027 ($ MILLION)
FIGURE 6 EUROPE ORTHOBIOLOGICS MARKET SHARE BY PRODUCTS 2018 & 2027 (%)
FIGURE 7 EUROPE ORTHOBIOLOGICS MARKET BY DEMINERALIZED BONE MATRIX (DBM) 2019-2027 ($ MILLION)
FIGURE 8 EUROPE ORTHOBIOLOGICS MARKET BY ALLOGRAFT 2019-2027 ($ MILLION)
FIGURE 9 EUROPE ORTHOBIOLOGICS MARKET BY BONE MORPHOGENETIC PROTEIN (BMP) 2019-2027 ($ MILLION)
FIGURE 10 EUROPE ORTHOBIOLOGICS MARKET BY VISCOSUPPLEMENTATION 2019-2027 ($ MILLION)
FIGURE 11 EUROPE ORTHOBIOLOGICS MARKET BY SYNTHETIC BONE SUBSTITUTES 2019-2027 ($ MILLION)
FIGURE 12 EUROPE ORTHOBIOLOGICS MARKET BY STEM CELL THERAPY 2019-2027 ($ MILLION)
FIGURE 13 EUROPE ORTHOBIOLOGICS MARKET BY OTHER PRODUCTS 2019-2027 ($ MILLION)
FIGURE 14 EUROPE ORTHOBIOLOGICS MARKET SHARE BY APPLICATION 2018 & 2027 (%)
FIGURE 15 EUROPE ORTHOBIOLOGICS MARKET BY SPINAL FUSION 2019-2027 ($ MILLION)
FIGURE 16 EUROPE ORTHOBIOLOGICS MARKET BY TRAUMA REPAIR 2019-2027 ($ MILLION)
FIGURE 17 EUROPE ORTHOBIOLOGICS MARKET BY RECONSTRUCTIVE SURGERY 2019-2027 ($ MILLION)
FIGURE 18 EUROPE ORTHOBIOLOGICS MARKET BY TENDON AND LIGAMENT 2019-2027 ($ MILLION)
FIGURE 19 EUROPE ORTHOBIOLOGICS MARKET BY OTHER APPLICATIONS 2019-2027 ($ MILLION)
FIGURE 20 PORTER’S FIVE FORCE MODEL
FIGURE 21 EUROPE ORTHOBIOLOGICS MARKET REGIONAL OUTLOOK 2018 & 2027 (%)
FIGURE 22 EUROPE ORTHOBIOLOGICS MARKET BY COUNTRY 2018 & 2027
FIGURE 23 THE UNITED KINGDOM ORTHOBIOLOGICS MARKET 2019-2027 ($ MILLION)
FIGURE 24 FRANCE ORTHOBIOLOGICS MARKET 2019-2027 ($ MILLION)
FIGURE 25 GERMANY ORTHOBIOLOGICS MARKET 2019-2027 ($ MILLION)
FIGURE 26 SPAIN ORTHOBIOLOGICS MARKET, 2019-2027 ($ MILLION)
FIGURE 27 ITALY ORTHOBIOLOGICS MARKET, 2019-2027 ($ MILLION)
FIGURE 28 REST OF EUROPE ORTHOBIOLOGICS MARKET 2019-2027 ($ MILLION)
FIGURE 29 ORTHOBIOLOGICS COMPANY MARKET SHARE 2018 (% )
- GEOGRAPHICAL ANALYSIS
- EUROPE
- THE UNITED KINGDOM
- FRANCE
- GERMANY
- SPAIN
- ITALY
- REST OF EUROPE
- EUROPE
- MARKET BY END USER
- HOSPITALS
- ORTHOPEDIC CLINICS
- MARKET BY PRODUCTS
- DEMINERALIZED BONE MATRIX (DBM)
- ALLOGRAFT
- BONE MORPHOGENETIC PROTEIN (BMP)
- VISCOSUPPLEMENTATION
- SYNTHETIC BONE SUBSTITUTES
- STEM CELL THERAPY
- OTHER PRODUCTS
- MARKET BY APPLICATION
- SPINAL FUSION
- TRAUMA REPAIR
- RECONSTRUCTIVE SURGERY
- TENDON AND LIGAMENT
- OTHER APPLICATIONS
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.